High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults
Overview
Authors
Affiliations
Rationale: Areas of increased lung attenuation visualized by computed tomography are associated with all-cause mortality in the general population. It is uncertain whether this association is attributable to interstitial lung disease (ILD).
Objectives: To determine whether high-attenuation areas are associated with the risk of ILD hospitalization and mortality in the general population.
Methods: We performed a cohort study of 6,808 adults aged 45-84 years sampled from six communities in the United States. High-attenuation areas were defined as the percentage of imaged lung volume with attenuation values between -600 and -250 Hounsfield units. An adjudication panel determined ILD hospitalization and death.
Measurements And Main Results: After adjudication, 52 participants had a diagnosis of ILD during 75,232 person-years (median, 12.2 yr) of follow-up. There were 48 hospitalizations attributable to ILD (crude rate, 6.4 per 10,000 person-years). Twenty participants died as a result of ILD (crude rate, 2.7 per 10,000 person-years). High-attenuation areas were associated with an increased rate of ILD hospitalization (adjusted hazard ratio, 2.6 per 1-SD increment in high-attenuation areas; 95% confidence interval, 1.9-3.5; P < 0.001), a finding that was stronger among men, African Americans, and Hispanics. High-attenuation areas were also associated with an increased rate of ILD-specific death (adjusted hazard ratio, 2.3; 95% confidence interval, 1.7-3.0; P < 0.001). Our findings were consistent among both smokers and nonsmokers.
Conclusions: Areas of increased lung attenuation are a novel risk factor for ILD hospitalization and mortality. Measurement of high-attenuation areas by screening and diagnostic computed tomography may be warranted in at-risk adults.
Gogali A, Kyriakopoulos C, Kostikas K Diagnostics (Basel). 2025; 15(4).
PMID: 40002659 PMC: 11854474. DOI: 10.3390/diagnostics15040509.
Komatsu M, Sugiyama F, Todoroki K, Takizawa M, Hanaoka M Cureus. 2025; 17(1):e77955.
PMID: 39996179 PMC: 11848692. DOI: 10.7759/cureus.77955.
Flack K, George M, Kim J, Hsu J, Podolanczuk A, Hoffman E Respir Med. 2025; 238:107955.
PMID: 39855480 PMC: 11851077. DOI: 10.1016/j.rmed.2025.107955.
Liu Z, Zheng Q, Li Z, Huang M, Zhong C, Yu R EBioMedicine. 2025; 112:105538.
PMID: 39753035 PMC: 11754162. DOI: 10.1016/j.ebiom.2024.105538.
Selvan K, Reicher J, Muelly M, Kalra A, Adegunsoye A BMC Pulm Med. 2024; 24(1):254.
PMID: 38783245 PMC: 11112769. DOI: 10.1186/s12890-024-03021-w.